Conventional treatment for heart failure could attenuate the changes in up- (CPN1, and C3) and down-regulated proteins (serum albumin precursor, albumin isoform X1, IGLC, and fetuin-B) in stage C CHF. The gene discussed is ALB; the disease is congestive heart failure.